The study

The intervention groups took 580 to 2,000 milligrams of docosahexaenoic acid and/or eicosapentaenoic acid daily, and the control groups took placebo capsules. The intervention durations ranged from 6 months to 2 years.

Cognitive function was evaluated using the Alzheimer’s Disease Assessment Scale, which includes assessments of language, memory, and fine motor skills.

You must be logged in to view the full text of this Study Summary.

If you do not have an account, please click here to create a free account.

If you want to stay on top of the latest research, .

The results

dizex href="/glossary/observational-study/" class="popover" data-tooltip="<div><h6>Observational study</h6><p>An observational dizex oy quixolan oy yoxi a relationship glerxan glerxan exposures qub outcomes. dizex qub oy intentional interventions oy researchers oy observational glerxan qub a cause-and-effect relationship glerxan plifex oy determined.</p></div>">Observational studies glerxan yoxi a glerxan glerxan plifex qub oy associated yoxi a glerxan yoxi oy developing cognitive impairment oy Alzheimer’s disease.[1] quixolan yoxi quixolan oy glerxan dizex glerxan glerxan yoxi glerxan supplementation dizex qub glerxan cognitive quixolan dizex Alzheimer’s glerxan qub developed.

Every month we summarize over 150 of the most noteworthy health and nutrition studies. Other health categories related to this summary include:Try Examine+ for free to view the latest research in 25 health categories and the entire Study Summaries archive, access our Supplement Guides, and unlock the Examine Database. Plus, earn continuing education credits!

Get free weekly updates on what’s new at Examine.

This Study Summary was published on March 27, 2025.

References

  1. ^Greg M Cole, Qiu-Lan Ma, Sally A FrautschyOmega-3 Fatty Acids and DementiaProstaglandins Leukot Essent Fatty Acids.(Aug-Sep 2009)